| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Longitude Capital Partners IV, LLC last filed a Form 4 in November 2023, as 10% Owner at LXEO. The filings on record cover 2 companies.
Historically, Longitude Capital Partners IV, LLC's trades have earned a middling insider score of 63/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +13.3%.
At the last filing, the largest reported position was 1,714,285 shares of VERA. Net of sales, the VERA filings show accumulation of 2,956,708 shares.
Longitude Capital Partners IV, LLC has 4 Form 4 filings on record from May 2021 to November 2023, across 2 companies: 10% Owner at Lexeo Therapeutics (LXEO), 2023; 10% Owner at Vera Therapeutics (VERA), 2021–2023.
The 7 reported transactions were 4 open-market purchases and 3 conversions.
Counted by filing, the open-market trades come to 4 purchases worth about $32.0M and no sales.
The largest open-market purchase was 1,714,285 shares of VERA at an average $7.00 on February 6, 2023, about $12.0M. Twelve months later VERA was up 446%.
Shares as reported in the last Form 4 for each company; the most recent is from November 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | LXEO Lexeo Therapeutics, Inc. | 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +21.5% | +61.6% | -21.6% | |
| Feb 6, 2023 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 1,714,285 | $7.00 | $11,999,995.00 | New | +8.5% | +445.9% | |
| Feb 10, 2022 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% |